The AGITG GAP Study: A Phase II Study of Perioperative Gemcitabine and Nab-Paclitaxel for Resectable Pancreas Cancer
the Australasian Gastro-Intestinal Trials Group (AGITG) GAP investigators, Andrew P. Barbour, Jaswinder S. Samra, Koroush S. Haghighi, Mark W. Donoghoe, Matthew Burge, Marion Harris, Yu Jo Chua, Jenna Mitchell, Nick O’Rourke, Howard Chan, Val Gebski, Sivakumar Gananadha, Daniel Croagh, James G. Kench, David Goldstein
Topics & Concepts
MedicineGemcitabinePerioperativePancreatic cancerSurgical oncologyChemotherapyInternal medicineNeoadjuvant therapyAdenocarcinomaCancerOncologyRadiologySurgeryBreast cancerPancreatic and Hepatic Oncology ResearchCancer, Stress, Anesthesia, and Immune ResponseCholangiocarcinoma and Gallbladder Cancer Studies